MedTrace Logo

Application of Surgical Navigation System in Sentinel Lymph Node of Breast Cancer Research

NCT02084784 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2018-06-07

No results posted yet for this study

Summary

The purpose of this study is to compare the sentinel lymph node (SLN) detection rate of early breast cancer patients between using Indocyanine green (ICG) and Methylene blue with a novel surgical navigation system.

Conditions

Interventions

DRUG

Indocyanine green

Subcutaneous injection around the areola with 2-4 points Indocyanine green with 1ml of 0.5%

DRUG

methylene blue

Subcutaneous injection around the areola with 2-4 points Methylene blue with 1ml of 1%

Sponsors & Collaborators

  • Chinese PLA General Hospital

    collaborator OTHER

  • Affiliated Cancer Hospital of Shantou University Medical College

    collaborator OTHER

  • Wannan Medical College Yijishan Hospital

    collaborator OTHER

  • Chinese Academy of Sciences

    lead OTHER_GOV

Principal Investigators

  • Chongwei Chi, doctor · Chinese Academy of Sciences

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02084784 on ClinicalTrials.gov